Ping Guo

969 total citations
23 papers, 695 citations indexed

About

Ping Guo is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ping Guo has authored 23 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Ping Guo's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Ping Guo is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Ping Guo collaborates with scholars based in China, United States and Japan. Ping Guo's co-authors include Ryo Nishikawa, Bo Hu, Yorihisa Imanishi, Takanori Hirose, Michael J. Jarzynka, Shi‐Yuan Cheng, Qiquan Zhou, Han Luo, Oliver Bögler and Tom Mikkelsen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Ping Guo

22 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Guo China 13 421 181 179 97 94 23 695
Claudia Abbruzzese Italy 20 619 1.5× 159 0.9× 134 0.7× 45 0.5× 187 2.0× 36 950
Limin Sun China 15 446 1.1× 179 1.0× 287 1.6× 63 0.6× 48 0.5× 28 729
Riccardo Chiusaroli United States 17 520 1.2× 152 0.8× 244 1.4× 115 1.2× 48 0.5× 22 898
Omar Benzakour United Kingdom 15 382 0.9× 177 1.0× 101 0.6× 177 1.8× 80 0.9× 33 869
Arata Nishimoto Japan 18 420 1.0× 141 0.8× 174 1.0× 74 0.8× 33 0.4× 36 802
Kun Guo China 10 800 1.9× 141 0.8× 209 1.2× 49 0.5× 52 0.6× 14 993
Nanxiang Xiong China 16 475 1.1× 326 1.8× 117 0.7× 75 0.8× 74 0.8× 65 887
Nicholas Dean United States 11 682 1.6× 107 0.6× 227 1.3× 51 0.5× 71 0.8× 37 976
Kaiming Xu United States 14 309 0.7× 97 0.5× 124 0.7× 85 0.9× 39 0.4× 22 589
Steven Messina‐Graham United States 8 351 0.8× 116 0.6× 201 1.1× 177 1.8× 44 0.5× 10 937

Countries citing papers authored by Ping Guo

Since Specialization
Citations

This map shows the geographic impact of Ping Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Guo more than expected).

Fields of papers citing papers by Ping Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Guo. The network helps show where Ping Guo may publish in the future.

Co-authorship network of co-authors of Ping Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Guo. A scholar is included among the top collaborators of Ping Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Guo. Ping Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xin, et al.. (2025). Lipid-lowering drug targets influence inflammatory bowel disease through gut microbiota and inflammatory cytokines. Journal of Lipid Research. 66(9). 100871–100871.
2.
Guo, Ping, Shiyuan Zhong, Yingying Ding, et al.. (2024). Urolithin A attenuates hexavalent chromium-induced small intestinal injury by modulating PP2A/Hippo/YAP1 pathway. Journal of Biological Chemistry. 300(9). 107669–107669. 1 indexed citations
3.
Jiang, Xinhang, Liping Chen, Chen Shen, et al.. (2023). Moderate body lipid accumulation in mice attenuated benzene-induced hematotoxicity via acceleration of benzene metabolism and clearance. Environment International. 178. 108113–108113. 6 indexed citations
4.
Yuan, Zhongshang, Lu Liu, Ping Guo, et al.. (2022). Likelihood-based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling. Science Advances. 8(9). eabl5744–eabl5744. 21 indexed citations
5.
Jiang, Xinhang, Wenxue Li, Ping Guo, et al.. (2022). Identification of miRNAs involved in liver injury induced by chronic exposure to cadmium. Toxicology. 469. 153133–153133. 14 indexed citations
6.
Wang, Tao, et al.. (2022). Experimental study of the development mode of gas-cap edge-water reservoir: A case study of Khasib reservoir of Halfaya oilfield in Iraq. Petroleum Exploration and Development. 49(3). 625–635. 3 indexed citations
7.
Wang, Xiaoping, Ping Guo, Jiahui Tian, et al.. (2021). LncRNA GAS5 participates in childhood pneumonia by inhibiting cell apoptosis and promoting SHIP-1 expression via downregulating miR-155. BMC Pulmonary Medicine. 21(1). 362–362. 9 indexed citations
8.
Bie, Liangyu, Dan Li, Wei Yan, et al.. (2020). HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab. Current Cancer Drug Targets. 20(9). 700–709. 14 indexed citations
9.
10.
Yu, Wendan, Yi‐Jun Hua, Huijuan Qiu, et al.. (2020). PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Cell Death and Disease. 11(7). 506–506. 120 indexed citations
11.
Guo, Ping, Chen Shen, Daochuan Li, et al.. (2020). SFPQ is involved in regulating arsenic-induced oxidative stress by interacting with the miRNA-induced silencing complexes. Environmental Pollution. 261. 114160–114160. 19 indexed citations
12.
Zhang, Rui, Jiali Wang, Baoshan Liu, et al.. (2020). Differentially expressed lncRNAs, miRNAs and mRNAs with associated ceRNA networks in a mouse model of myocardial ischemia/reperfusion injury. Molecular Medicine Reports. 22(3). 2487–2495. 10 indexed citations
13.
Sinha, Krishna Murari, Chieh Tseng, Ping Guo, et al.. (2019). Hypoxia‐inducible factor 1α (HIF‐1α) is a major determinant in the enhanced function of muscle‐derived progenitors from MRL/MpJ mice. The FASEB Journal. 33(7). 8321–8334. 21 indexed citations
14.
Li, Hu, et al.. (2018). Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis. Oncology Reports. 40(2). 647–658. 5 indexed citations
15.
Guo, Ping, et al.. (2017). Identification of miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma. Molecular Medicine Reports. 16(4). 4179–4186. 7 indexed citations
16.
Zhou, Qiang, et al.. (2013). A Novel Axial-Stress Bioreactor System Combined with a Substance Exchanger for Tissue Engineering of 3D Constructs. Tissue Engineering Part C Methods. 20(3). 205–214. 29 indexed citations
17.
Luo, Han, Ping Guo, & Qiquan Zhou. (2012). Role of TLR4/NF-κB in Damage to Intestinal Mucosa Barrier Function and Bacterial Translocation in Rats Exposed to Hypoxia. PLoS ONE. 7(10). e46291–e46291. 67 indexed citations
18.
Hu, Bo, Ping Guo, Ifat Bar-Joseph, et al.. (2007). Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene. 26(38). 5577–5586. 159 indexed citations
19.
Jabasini, Mohammad, Feng Xu, Mohamad Reza Mohamadi, et al.. (2005). Multiplex PCR with Multichannel Microchip Electrophoresis: An Ultrafast Analysis for Genetic Diseases. Journal of Chromatographic Science. 43(5). 221–225. 5 indexed citations
20.
Guo, Ping, Yorihisa Imanishi, Frank C. Cackowski, et al.. (2005). Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 γ 2 Correlates with the Invasiveness of Human Glioma. American Journal Of Pathology. 166(3). 877–890. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026